These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4376517)

  • 1. Early events in transformation of human cord leukobytes by Epstain-Barr virus: induction of DNA synthesis, mitosis and the virus-associated nuclear antigen synthesis.
    Aya T; Osato T
    Int J Cancer; 1974 Sep; 14(3):341-7. PubMed ID: 4376517
    [No Abstract]   [Full Text] [Related]  

  • 2. Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence.
    Ernberg I; Klein G; Kourilsky FM; Silvestre D
    J Natl Cancer Inst; 1974 Jul; 53(1):61-5. PubMed ID: 4365906
    [No Abstract]   [Full Text] [Related]  

  • 3. Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine.
    Hampar B; Derge JG; Nonoyama M; Chang SY; Tagamets A; Showalter SD
    Virology; 1974 Nov; 62(1):71-89. PubMed ID: 4371498
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
    Yang CS; Hewetson JF
    Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
    [No Abstract]   [Full Text] [Related]  

  • 5. Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies.
    Huang DP; Ho JH; Henle W; Henle G
    Int J Cancer; 1974 Nov; 14(5):580-8. PubMed ID: 4142471
    [No Abstract]   [Full Text] [Related]  

  • 6. The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines.
    Gergely L; Klein G; Ernberg I
    Int J Cancer; 1971 Mar; 7(2):293-302. PubMed ID: 4932228
    [No Abstract]   [Full Text] [Related]  

  • 7. Epstein-barr-virus nuclear antigen.
    Vonka V; Hirsch I
    Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequence of spontaneous Epstein-Barr virus activation and selective DNA synthesis in activated cells in the presence of hydroxyurea.
    Hampar B; Derge JG; Martos LM; Tagamets MA; Burroughs MA
    Proc Natl Acad Sci U S A; 1972 Sep; 69(9):2589-93. PubMed ID: 4341700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on Epstein-Barr virus-associated antigens.
    Ernberg I
    Ann N Y Acad Sci; 1975 Jun; 254():516-22. PubMed ID: 170849
    [No Abstract]   [Full Text] [Related]  

  • 10. The rescue of Epstein--Barr virus from primary cultured cells of nasopharyngeal carcinoma.
    Takada M; Murata M; Takei M; Nakagawa S; Okumura H; Kawamura A
    Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):177-89. PubMed ID: 228891
    [No Abstract]   [Full Text] [Related]  

  • 11. Observations on the resistance of Fpstein-Barr virus DNA synthesis to hydroxyurea.
    Mele J; Glaser R; Nonoyama M; Zimmerman J; Rapp F
    Virology; 1974 Nov; 62(1):102-11. PubMed ID: 4371583
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine.
    Hampar B; Derge JG; Martos LM; Walker JL
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3185-9. PubMed ID: 4332012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.
    Klein G; Dombos L; Gothoskar B
    Int J Cancer; 1972 Jul; 10(1):44-57. PubMed ID: 4122458
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular reactions against Burkitt Lymphoma cells. I. Colony inhibition with effector cells from patients with Burkitt's lymphoma.
    Hewetson JF; Golub SH; Klien G; Singh S
    Int J Cancer; 1972 Jul; 10(1):142-9. PubMed ID: 4350508
    [No Abstract]   [Full Text] [Related]  

  • 15. Specific neutralizing antibodies in Epstein-Barr virus associated diseases.
    Rocchi G; Hewetson J; Henle W
    Int J Cancer; 1973 May; 11(3):637-47. PubMed ID: 4364719
    [No Abstract]   [Full Text] [Related]  

  • 16. Superinfection with Epstein-Barr virus of human lymphoid cell lines of different origin.
    Adams A; Klein G
    Nat New Biol; 1973 Apr; 242(121):234-6. PubMed ID: 4349776
    [No Abstract]   [Full Text] [Related]  

  • 17. Two distinct antigenic components in an Epstein-Barr virus-related early product induced by halogenated pyrimidines in non-producing human lymphoblastoid cells.
    Sugawara K; Osato T
    Nat New Biol; 1973 Jun; 243(128):209-10. PubMed ID: 4351756
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of nuclear antigen (EBNA) synthesis without transformation in human cord lymphocytes by P3HR-1 strain of Epstein-Barr virus.
    Yamamoto N; Hinuma Y
    Virology; 1978 Sep; 89(2):623-6. PubMed ID: 213884
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens.
    Pearson GR; Orr TW
    J Natl Cancer Inst; 1976 Mar; 56(3):485-8. PubMed ID: 176393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-induced antigens - a review.
    Klein G
    IARC Sci Publ (1971); 1975; (11 Pt 1):293-308. PubMed ID: 190131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.